SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam Regulatory News (TEAM)

Share Price Information for Team (TEAM)

Share Price is delayed by 15 minutes
Get Live Data
16.00    0.00 (0.00%)
Bid:
15.00
Ask:
17.00
Spread: 2.00 (13.333%)
Market Cap: £17.55m
TEAM Live PriceLast checked at - London Stock Exchange

Intraday Team Share Chart

Form 8.3 - [Loreto Ltd]

7 Apr 2021 18:15

RNS Number : 7456U
Team PLC
07 April 2021
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

LORETO LIMITED

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and

beneficiaries must be named.

IMPERIUM TRUST COMPANY LTD AS TRUSTEES OF THE STAR OF THE SEA TRUST SETTLOR - JEAN MARTIN POPIEL BENS - JEAN MARTIN POPIEL & KAREN POPIEL

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

TEAM plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

06/04/2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

Ordinary Shares

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

284,090

1.7

(2) Cash-settled derivatives:

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

284,090

1.7

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a

long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description

e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option

relates

Exercise price per unit

Type

e.g.

American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

 

(c) Attachments

 

 

 

Date of disclosure:

07/04/2021

Contact name:

Jenny Chester

Telephone number*:

0153 4877 210 (TEAM plc)

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at w ww.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETUBABRAOUSRAR
Date   Source Headline
4th Dec 20255:45 pmRNSForm 8.3 - TEAM PLC
4th Dec 20254:49 pmRNSForm 8.3 - TEAM Plc
4th Dec 202511:42 amGNWForm 8.5 (EPT/RI) - Team Plc
1st Dec 202510:40 amGNWForm 8.5 (EPT/RI) - Team Plc
28th Nov 20252:45 pmRNSForm 8.3 - Team PLC
28th Nov 20252:20 pmRNSForm 8.3 - Team plc
28th Nov 202510:13 amGNWForm 8.5 (EPT/RI) - Team Plc
27th Nov 20255:20 pmRNSHolding(s) in Company
27th Nov 202511:52 amGNWForm 8.5 (EPT/RI) - Team Plc
27th Nov 20257:30 amRNSRECOMMENDED ACQUISITION OF W.H. IRELAND GROUP PLC
27th Nov 20257:26 amRNSForm 8.3 - TEAM Plc
26th Nov 20257:04 amRNSForm 8.3 - Team plc
21st Nov 20255:00 pmRNSForm 8 Opening Position Disclosure
21st Nov 20253:45 pmRNSHolding(s) in Company
21st Nov 202511:50 amGNWForm 8.5 (EPT/RI) - Team Plc
17th Nov 202510:28 amGNWForm 8.5 (EPT/RI) - Team Plc
14th Nov 20253:13 pmRNSForm 8.3 - Team Plc
14th Nov 202511:26 amGNWForm 8.5 (EPT/RI) - Team Plc
14th Nov 20259:26 amGNWForm 8.3 - [TEAM PLC - Opening Disclosure - 13 11 2025] - (CGAML)
13th Nov 20259:37 amRNSDisclosure Table
13th Nov 20258:59 amRNSReplacement- Statement regarding media speculation
13th Nov 20258:38 amRNSDisclosure Table
13th Nov 20258:15 amRNSStatement regarding recent media speculation
13th Nov 20257:49 amRNSDisclosure Table
13th Nov 20257:00 amRNSPossible Offer
8th Sep 20256:00 pmRNSHolding(s) in Company
3rd Sep 20253:42 pmRNSHolding(s) in Company
7th Aug 20257:00 amRNS-RDirectorsTalk Interview
6th Aug 20257:00 amRNSLaunch of UCITS Fund
16th Jul 20252:35 pmRNSChange of Registered Office Address
30th Jun 20257:06 amRNSHalf-year Report
19th Jun 202512:45 pmRNSHolding(s) in Company
25th Apr 20256:16 pmRNSHolding(s) in Company
25th Apr 20257:00 amRNSResult of AGM
8th Apr 20252:24 pmRNSEquity Subscription
7th Apr 20254:11 pmRNSHolding(s) in Company
3rd Apr 202512:30 pmRNSUpdated Notice of AGM
27th Mar 20256:28 pmRNSDirector’s Dealing
27th Mar 20252:47 pmRNSDirector/PDMR Shareholding
25th Mar 20254:30 pmRNSDirector/PDMR Shareholding
24th Mar 20254:40 pmRNSDirector's Dealing - Replacement
24th Mar 202511:21 amRNSDirector's Dealing
21st Mar 20252:15 pmRNSEquity Subscription
20th Mar 20257:00 amRNSProposed Board Changes and Notice of AGM
4th Mar 20258:15 amRNSDirector/PDMR Shareholding
3rd Mar 20257:10 amRNSFund Raise and Issue of Equity
3rd Mar 20257:00 amRNSFinal Results
29th Jan 20254:30 pmRNSTotal Voting Rights Update
24th Jan 20253:25 pmRNSResult of EGM
7th Jan 20251:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.